⚠️  Treatment line integration not available - skipping treatment line features
{
  "patient_id": "AK",
  "requested_levels": [
    "L1",
    "L2",
    "L3"
  ],
  "generated_at": "2026-01-31T00:09:33.145562",
  "levels": {
    "L1": {
      "is_preview": false,
      "effective_assembly": "GRCh38",
      "inputs_used": {
        "mutations": [
          {
            "gene": "MBD4",
            "hgvs_p": "p.K431Nfs*54",
            "hgvs_c": "c.1293delA",
            "consequence": "frameshift_variant",
            "classification": "pathogenic"
          },
          {
            "gene": "PDGFRA",
            "hgvs_p": "p.S755P",
            "hgvs_c": "c.2263T>C",
            "consequence": "missense_variant",
            "classification": "VUS"
          }
        ],
        "tumor_context": {
          "completeness_score": 0.55,
          "somatic_mutations": [],
          "msi_status": "MSS",
          "pd_l1_status": "POSITIVE",
          "pd_l1_cps": 10,
          "er_status": "WEAKLY_POSITIVE",
          "er_percent": 50,
          "genome_build": "GRCh38"
        }
      },
      "efficacy": {
        "drugs": [
          {
            "name": "MockParib",
            "confidence": 0.95,
            "rationale": "High HRD inferred from Sig7"
          },
          {
            "name": "MockPlatin",
            "confidence": 0.88,
            "rationale": "Platinum sensitivity retention"
          }
        ],
        "pathway_scores": {
          "HRD": 9.5,
          "CellCycle": 8.0
        },
        "provenance": {
          "model": "evo2_1b",
          "version": "v2.1"
        }
      },
      "completeness": {
        "level": "L1",
        "level_name": "Partial",
        "completeness_score": 0.55,
        "has_germline": true,
        "has_somatic_ngs": false,
        "has_ihc": true,
        "has_hrd": false,
        "has_tmb": false,
        "has_expression": false,
        "has_ca125": false,
        "missing": [
          "NGS somatic mutations (genomic coordinates)",
          "HRD score",
          "TMB score",
          "RNA expression data",
          "CA-125 lab values"
        ],
        "confidence_cap": 0.6
      }
    },
    "L2": {
      "is_preview": true,
      "effective_assembly": "GRCh38",
      "inputs_used": {
        "mutations": [
          {
            "gene": "MBD4",
            "hgvs_p": "p.K431Nfs*54",
            "hgvs_c": "c.1293delA",
            "consequence": "frameshift_variant",
            "classification": "pathogenic"
          },
          {
            "gene": "PDGFRA",
            "hgvs_p": "p.S755P",
            "hgvs_c": "c.2263T>C",
            "consequence": "missense_variant",
            "classification": "VUS"
          },
          {
            "gene": "TP53",
            "hgvs_p": "p.R273H",
            "hgvs_c": "c.818G>A",
            "consequence": "missense_variant",
            "data_origin": "scenario_inferred",
            "chrom": "17",
            "pos": 7673802,
            "ref": "G",
            "alt": "A"
          }
        ],
        "tumor_context": {
          "completeness_score": 0.7,
          "somatic_mutations": [
            {
              "gene": "TP53",
              "hgvs_p": "p.R273H",
              "consequence": "missense_variant"
            }
          ],
          "hrd_score": 18.0,
          "hrd_status": "LOW",
          "tmb": 3.0,
          "tmb_status": "LOW",
          "msi_status": "MSS",
          "pd_l1_status": "POSITIVE",
          "pd_l1_cps": 10,
          "er_status": "WEAKLY_POSITIVE",
          "er_percent": 50,
          "sig7_exposure": 0.88,
          "genome_build": "GRCh38"
        }
      },
      "efficacy": {
        "drugs": [
          {
            "name": "MockParib",
            "confidence": 0.95,
            "rationale": "High HRD inferred from Sig7"
          },
          {
            "name": "MockPlatin",
            "confidence": 0.88,
            "rationale": "Platinum sensitivity retention"
          }
        ],
        "pathway_scores": {
          "HRD": 9.5,
          "CellCycle": 8.0
        },
        "provenance": {
          "model": "evo2_1b",
          "version": "v2.1"
        }
      },
      "completeness": {
        "level": "L2",
        "level_name": "Good",
        "completeness_score": 0.7,
        "has_germline": true,
        "has_somatic_ngs": true,
        "has_ihc": true,
        "has_hrd": true,
        "has_tmb": true,
        "has_expression": false,
        "has_ca125": false,
        "missing": [
          "RNA expression data",
          "CA-125 lab values"
        ],
        "confidence_cap": null
      }
    },
    "L3": {
      "is_preview": true,
      "effective_assembly": "GRCh38",
      "inputs_used": {
        "mutations": [
          {
            "gene": "MBD4",
            "hgvs_p": "p.K431Nfs*54",
            "hgvs_c": "c.1293delA",
            "consequence": "frameshift_variant",
            "classification": "pathogenic"
          },
          {
            "gene": "PDGFRA",
            "hgvs_p": "p.S755P",
            "hgvs_c": "c.2263T>C",
            "consequence": "missense_variant",
            "classification": "VUS"
          },
          {
            "gene": "TP53",
            "hgvs_p": "p.R273H",
            "hgvs_c": "c.818G>A",
            "consequence": "missense_variant",
            "data_origin": "scenario_inferred",
            "chrom": "17",
            "pos": 7673802,
            "ref": "G",
            "alt": "A"
          }
        ],
        "tumor_context": {
          "completeness_score": 0.85,
          "somatic_mutations": [
            {
              "gene": "TP53",
              "hgvs_p": "p.R273H",
              "consequence": "missense_variant"
            }
          ],
          "hrd_score": 18.0,
          "hrd_status": "LOW",
          "tmb": 3.0,
          "tmb_status": "LOW",
          "msi_status": "MSS",
          "pd_l1_status": "POSITIVE",
          "pd_l1_cps": 10,
          "er_status": "WEAKLY_POSITIVE",
          "er_percent": 50,
          "expression": {
            "BRCA1": 7.8,
            "BRCA2": 7.0,
            "PALB2": 7.2,
            "RAD51C": 6.8,
            "RAD51D": 7.2,
            "BRIP1": 7.2,
            "BARD1": 7.2,
            "ATM": 7.2,
            "ATR": 7.2,
            "CHEK1": 7.2,
            "CHEK2": 7.2,
            "RAD51": 7.2,
            "RAD52": 7.2,
            "RAD54L": 7.2,
            "FANCA": 7.2,
            "FANCB": 7.2,
            "FANCC": 7.2,
            "FANCD2": 7.2,
            "FANCE": 7.2,
            "FANCF": 7.2,
            "FANCG": 7.2,
            "MRE11A": 7.2,
            "RAD50": 7.2,
            "NBN": 7.2,
            "XRCC2": 7.2,
            "XRCC3": 7.2,
            "PIK3CA": 7.8,
            "PIK3CB": 7.8,
            "PIK3CD": 7.8,
            "PIK3CG": 7.8,
            "PIK3R1": 7.8,
            "PIK3R2": 7.8,
            "PIK3R3": 7.8,
            "AKT1": 7.8,
            "AKT2": 7.8,
            "AKT3": 7.8,
            "PTEN": 7.8,
            "TSC1": 7.8,
            "TSC2": 7.8,
            "MTOR": 7.8,
            "PDK1": 7.8,
            "RPS6KB1": 7.8,
            "RPS6KB2": 7.8,
            "EIF4EBP1": 7.8,
            "RHEB": 7.8,
            "RICTOR": 7.8,
            "RPTOR": 7.8,
            "VEGFA": 10.2,
            "VEGFB": 9.0,
            "VEGFC": 8.2,
            "VEGFD": 8.2,
            "KDR": 9.1,
            "FLT1": 8.6,
            "FLT4": 8.2,
            "ANGPT1": 8.8,
            "ANGPT2": 9.2,
            "TEK": 8.5,
            "TIE1": 8.2,
            "PECAM1": 8.2,
            "VWF": 8.2,
            "ENG": 8.2,
            "KIT": 8.2,
            "PDGFRA": 8.2,
            "PDGFRB": 8.2,
            "KRAS": 7.5,
            "NRAS": 7.5,
            "HRAS": 7.5,
            "BRAF": 7.5,
            "RAF1": 7.5,
            "MAP2K1": 7.5,
            "MAP2K2": 7.5,
            "MAPK1": 7.5,
            "MAPK3": 7.5,
            "NF1": 7.5,
            "RASA1": 7.5,
            "RASA2": 7.5,
            "SPRED1": 7.5,
            "SPRED2": 7.5,
            "ABCB1": 8.7,
            "ABCC1": 8.1,
            "ABCC2": 7.6,
            "ABCC3": 7.6,
            "ABCC4": 7.6,
            "ABCC5": 7.6,
            "ABCC6": 7.6,
            "ABCG2": 8.3,
            "SLC22A1": 7.6,
            "SLC22A2": 7.6,
            "SLC22A3": 7.6,
            "CD274": 7.8,
            "CXCL9": 7.2,
            "GZMB": 7.5,
            "IFNG": 7.4,
            "TNF": 7.4
          },
          "expression_source": "synthetic_baseline+scenario_overrides",
          "ca125_value": 2800.0,
          "ca125_units": "U/mL",
          "sig7_exposure": 0.92,
          "genome_build": "GRCh38"
        }
      },
      "efficacy": {
        "drugs": [
          {
            "name": "MockParib",
            "confidence": 0.95,
            "rationale": "High HRD inferred from Sig7"
          },
          {
            "name": "MockPlatin",
            "confidence": 0.88,
            "rationale": "Platinum sensitivity retention"
          }
        ],
        "pathway_scores": {
          "HRD": 9.5,
          "CellCycle": 8.0
        },
        "provenance": {
          "model": "evo2_1b",
          "version": "v2.1"
        }
      },
      "completeness": {
        "level": "L2",
        "level_name": "Good",
        "completeness_score": 0.85,
        "has_germline": true,
        "has_somatic_ngs": true,
        "has_ihc": true,
        "has_hrd": true,
        "has_tmb": true,
        "has_expression": true,
        "has_ca125": true,
        "missing": [],
        "confidence_cap": null
      }
    }
  },
  "tests_needed": [
    {
      "test": "HRD Assay (Myriad MyChoice or similar)",
      "unlocks": [
        "L2: PARP Sensitivity Prediction",
        "L2: Platinum Response"
      ],
      "why": "Required to determine if the tumor has Homologous Recombination Deficiency (HRD), a key biomarker for PARP inhibitors.",
      "status": "missing",
      "source": "recommended"
    },
    {
      "test": "Comprehensive Genomic Profiling (CGP) for TMB",
      "unlocks": [
        "L2: Immunotherapy Eligibility"
      ],
      "why": "Tumor Mutational Burden (TMB) predicts response to checkpoint inhibitors (Keytruda, etc).",
      "status": "missing",
      "source": "recommended"
    },
    {
      "test": "RNA Sequencing (Transcriptome)",
      "unlocks": [
        "L3: Pathway Activation Scores",
        "L3: Mechanism of Action"
      ],
      "why": "needed to measure actual pathway activity (e.g. VEGF, MAPK) beyond just DNA mutations.",
      "status": "missing",
      "source": "recommended"
    },
    {
      "test": "Serum CA-125 Level",
      "unlocks": [
        "L3: Tumor Burden Baseline"
      ],
      "why": "Baseline CA-125 is critical for tracking response dynamics.",
      "status": "missing",
      "source": "recommended"
    }
  ]
}
